Stay updated with breaking news from Akeel Mithani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, announces that Tilde Sciences, specializing in the development and commercialization of specialty pharmaceuticals, has chosen AscellaHealth’s Specialty Pharmacy, Optime Care as its exclusive distribution,...
Adam KlasfeldMay 18th, 2021, 2:29 pm Former pharmaceutical executive Martin Shkreli points as he exits the courthouse after the jury issued a verdict in his case at the U.S. District Court for the Eastern District of New York, Aug. 4, 2017 in the Brooklyn borough of New York City. The Federal Trade Commission accused disgraced pharmaceutical executive Martin Shkreli on Tuesday of having destroyed evidence relevant to a lawsuit that could lead to his lifetime ban from the industry. Regulators claim that the convicted fraudster invoked his Fifth Amendment right against self-incrimination when...
Pharma Bro Martin Shkreli faces class-action suit over drug ‘monopoly’ Gustaf Kilander © Provided by The Independent Pharma Bro Martin Shkreli, who became infamous when he raised the price of Daraprim by over 4,100 per cent, is facing a class-action lawsuit from health insurers who say he created a drug monopoly around the HIV medication. Insurers Blue Cross and Blue Shield of Minnesota sued Mr Shkreli in a Manhattan federal court claiming that he and his company Vyera Pharmaceuticals facilitated the monopoly on the drug by stopping “competitors from obtaining the Dar...